Takeda Pharmaceutical Cash Flow Statement (2017-2026) | TAK

Cash Flow Statement Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Operating Activities
Net Income (Quarter)
2.82B0.70B0.76B2.65B1.59B0.49B0.67B1.56B1.32B1.94B0.02B1.23B1.14B2.37B-1.00B1.26B1.10B2.78B-3.52B-3.58B
Share-based Compensation (Quarter)
0.08B0.11B0.10B0.10B0.10B0.12B0.12B0.11B0.11B0.13B0.13B0.12B0.10B0.14B0.12B0.12B0.11B0.13B0.12B0.13B
Gains from Investment Securities (Quarter)
0.00B0.00B0.02B0.01B0.00B0.02B0.01B0.00B0.00B0.00B0.09B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B
Asset Writedowns and Impairment (Quarter)
0.00B0.01B0.12B0.34B0.11B0.16B0.04B0.17B0.06B0.82B0.05B0.11B0.17B0.07B0.01B0.45B0.02B0.58B0.05B0.32B
Non-cash Items (Quarter)
1.85B2.46B3.30B3.57B0.81B2.24B3.07B2.38B1.06B1.84B1.31B2.12B1.32B2.21B2.64B1.77B1.72B2.93B2.57B0.88B
Cash from Operations (Quarter)
1.52B2.12B3.06B3.23B0.65B1.60B2.68B2.22B0.67B1.38B0.99B1.88B1.09B1.88B2.52B1.46B1.49B2.57B2.43B1.58B
Depreciation, Depletion & Amortization
Depreciation & Amortization (CF) (Quarter)
1.31B1.28B1.30B1.31B1.22B1.22B1.25B1.22B1.25B1.27B1.27B1.26B1.23B1.29B1.23B1.24B1.26B1.26B1.24B1.04B
Change in Working Capital
Change in Receivables (Quarter)
-0.38B-0.12B1.21B0.39B-0.14B0.09B0.09B0.52B-0.66B0.12B0.10B0.50B-0.31B-0.07B0.08B-0.09B0.33B-0.07B-0.07B-0.62B
Change in Inventory (Quarter)
-0.19B-0.04B-0.13B-0.06B-0.07B-0.05B-0.13B-0.34B-0.21B-0.34B-0.34B0.09B-0.06B-0.28B0.14B-0.03B-0.09B-0.20B-0.25B0.12B
Change in Account Payables (Quarter)
-0.23B0.14B0.06B1.09B-0.75B-0.29B-0.05B0.45B-0.25B-0.10B0.48B-0.21B-0.24B0.00B0.13B0.07B-0.19B0.11B0.02B0.03B
Change in Taxes (Quarter)
-0.33B-0.39B-0.25B-0.35B-0.19B-0.66B-0.41B-0.19B-0.41B-0.51B-0.34B-0.27B-0.24B-0.34B-0.21B-0.33B-0.25B-0.37B-0.16B-0.41B
Investing Activities
Capital Expenditures (Quarter)
-0.27B-0.28B-0.24B1.81B-0.33B-0.21B-0.24B1.86B-0.34B-0.26B-0.32B2.07B-0.37B-0.33B-0.30B2.31B-0.33B-0.27B-0.27B1.95B
Sales of Property, Plant and Equipment (Quarter)
0.00B0.00B0.00B0.01B0.00B0.00B-0.00B0.01B0.00B0.06B0.00B0.00B0.00B0.00B0.00B0.00B0.04B0.00B0.00B
Change in Intangibles (Quarter)
-0.11B-0.12B-0.19B-0.14B-0.43B-0.08B-0.12B-3.09B-1.63B-0.22B-0.20B-0.13B-0.52B-0.08B-0.08B-0.29B-0.19B-0.09B-1.16B-0.11B
Acquisitions (Quarter)
-0.25B-0.19B
Divestments (Quarter)
0.02B0.22B0.00B-0.00B0.13B0.02B0.04B0.01B0.07B0.20B0.00B0.02B0.00B
Change in Acquisitions & Divestments (Quarter)
0.00B0.09B0.05B-0.20B0.05B0.09B0.02B-0.18B0.00B0.00B0.00B-0.03B0.03B0.12B0.02B-0.18B0.01B0.02B0.01B-0.05B
Cash from Investing Activities (Quarter)
-0.64B-0.30B-0.61B-0.22B-0.73B-0.20B-0.33B-3.31B-1.94B-0.42B-0.51B-0.41B-1.01B-0.50B-0.76B-0.13B-0.23B-0.33B-1.49B-0.37B
Financing Activities
Other financing activities (Quarter)
-0.32B0.16B0.12B0.04B-0.32B0.22B0.23B-0.23B-0.49B-0.05B0.18B0.14B-0.71B-0.06B0.25B0.43B-0.60B0.35B0.32B-0.18B
Cash from Financing Activities (Quarter)
-3.75B-2.25B-1.48B-2.10B-1.67B-0.38B-3.08B-0.05B-0.42B-0.97B-0.66B-0.39B2.03B-0.74B-4.31B-1.98B-1.49B-0.08B-1.25B-0.49B
Change in Capital Stock
Net Shares Issued and Repurchased (Quarter)
Net Equity Issued and Repurchased (Quarter)
0.00B
Dividend Payments
Dividends Paid - Common (Quarter)
-1.21B-0.09B-1.16B4.80B-1.00B-0.08B-0.91B4.14B-0.95B-0.06B-0.94B3.82B-0.89B-0.06B-0.96B3.91B-1.00B-0.06B-0.97B3.92B
Additional items
Exchange Rate Effect (Quarter)
0.03B0.00B0.05B0.17B0.17B0.07B-0.07B-0.00B0.11B0.03B-0.02B0.07B0.11B-0.28B0.15B-0.06B-0.02B0.09B0.15B0.01B
Change in Cash (Quarter)
-2.87B-0.43B0.97B0.91B-1.75B1.03B-0.73B-1.14B-1.69B-0.02B-0.18B1.07B2.12B0.64B-2.55B-0.65B-0.23B2.16B-0.32B-0.39B
Free Cash Flow (Quarter)
1.80B2.40B3.30B1.42B0.98B1.81B2.91B0.36B1.01B1.64B1.31B-0.19B1.46B2.22B2.82B-0.86B1.82B2.84B2.70B-0.37B
Net Cash Flow (Quarter)
-2.87B-0.43B0.97B0.91B-1.75B1.03B-0.73B-1.14B-1.69B-0.02B-0.18B1.07B2.12B0.64B-2.55B-0.65B-0.23B2.16B-0.32B0.71B